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A hepatocyte growth factor (HGF) that stimulates DNA synthesis of adult rat hepatocytes in primary cul- 
ture was purified as a homogeneous material from platelets of 1000 rats by a four-step rocedure: stimula- 
tion of its release from platelets by thrombin, cation-exchanger fast protein liquid chromatography (FPLC) 
on a Mono S column, heparin-Sepharose CL-6B chromatography, and reverse-phase HPLC on a C 4 col- 
umn. The purified HGF stimulated DNA synthesis of adult rat hepatocytes in primary culture at 1 ng/ml 
and was maximally effective at 5 ng/ml, being about twice as potent as EGF at this concentration. HGF 
did not stimulate DNA synthesis of Swiss 3T3 cells. It was found to be a heat- and acid-labile protein that 
was inactivated by reduction with dithiothreitol. The purified HGF had a molecular mass of 82 kDa, as 
estimated by SDS-PAGE, and was found to be a heterodimer which dissociated into a large subunit of 
69 kDa and a small one of 34 kDa by SDS-PAGE under educing conditions. These biological and chemical 
properties howed that HGF was not identical with any known growth factors, including platelet-derived 
growth factor (PDGF). 
Hepatocyte growth factor; Primary cultured hepatocyte; Platelet; Heterodimer 
1. INTRODUCTION 
Liver is known to regenerate actively after par- 
tial hepatectomy and there have been many at- 
tempts to identify a humoral factor that stimulates 
proliferation of liver cells (hepatotropic factor) [1]. 
However, no such factor has yet been purified or 
characterized [2], because no simple, reproducible 
and sensitive in vitro method is available for its 
assay. In the last decade, several studies including 
our own [3-8] have demonstrated that adult rat 
hepatocytes in primary culture, which retain many 
liver-specific functions and respond to various hor- 
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mones in the same way as in vivo [9-11], can pro- 
liferate at low cell density when insulin and 
epidermal growth factor (EGF) are added to the 
culture medium. Thus, primary cultures of adult 
rat hepatocytes are a suitable in vitro assay system 
for identification and purification of a 
hepatotropic factor. Using this in vitro assay 
system, we previously purified a hepatotropic fac- 
tor that strongly stimulated DNA synthesis of 
mature rat hepatocytes from the serum of partially 
hepatectomized rats, and named this factor 
hepatocyte growth factor (HGF) or hepatotropin 
[12]. Subsequently, several groups have found that 
HGF is present at a high concentration i  rat 
platelets and is released on aggregation of the 
platelets [12-14]. Recently, we purified HGF from 
rat platelets and demonstrated that it is a new 
growth factor differing from platelet-derived 
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growth factor (PDGF) in some chemical and 
biological properties [15]. However, we could not 
determine the subunit structure of this HGF from 
rat platelets, because our preparation was not com- 
pletely homogeneous. 
Here, we report on the complete purification of 
HGF from rat platelets with reverse-phase HPLC 
on a C4 column as the final purification step. We 
also report studies showing that HGF is a 
heterodimer with a molecular mass of 82 kDa on 
SDS-PAGE and is composed of two polypeptides 
of 69 and 34 kDa, respectively. 
2. MATERIALS AND METHODS 
tion of DNA synthesis of adult rat hepatocytes in
primary culture. 
2.4. Secretion of HGFfrom rat platelets 
Rat platelets were isolated as 99% purity in a 
yield of about 10 l° platelets from the blood of 100 
rats as described [15]. The platelets were suspended 
at 1 × 10 l° platelets/ml in phosphate-buffered 
saline (PBS) and incubated with 2 U/ml  of pure 
thrombin for 10 min at 25°C to induce aggrega- 
tion. After 10 min, phenylmethylsulfonyl fluoride 
was added at a final concentration of 1 mM. Ag- 
gregates of platelets were precipitated by cen- 
trifugation and the resulting supernatant was used 
as the starting material for purification of HGF. 
2.1. Materials 
A mono S column and heparin-Sepharose 
CL-6B were obtained from Pharmacia (Uppsala). 
DE 52 was purchased from Sigma. [methyl- 
3H]Thymidine (54.2 Ci/mmol) was from the 
Radiochemical Centre. Mouse EGF was purified 
from the submaxillary glands of male adult mice 
by the method of Savage and Cohen [16]. Recom- 
binant human EGF was a gift from Earth 
Chemical Co., Akoh. 
2.2. Primary culture of adult rat hepatocytes 
Parenchymal hepatocytes were isolated from 
adult Wistar rats (180-250 g) by perfusion of the 
liver in situ with collgenase. The isolated cells were 
cultured as monolayers in Williams medium E sup- 
plemented with 5°70 calf serum, 2 nM insulin and 
1/~M dexamethasone [17]. The initial cell density 
was 2.5 x 105 cells/2 cm diameter wells of Linbro 
multi-well plastic dishes coated with type I col- 
lagen. After 4 h, the medium was changed to 
serum-free Williams medium E with aprotinin 
(bovine pancreatic trypsin inhibitor) at 0.1/~g/ml. 
2.3. Assay of HGF activity 
The test sample or insulin (0.1 #M) and EGF 
(20 ng/ml) were added to the culture 20 h after 
plating. After further incubation for 12 h, 
[3H]thymidine (2.5/zCi/ml, 0.27 Ci/mmol) was 
added to the medium and culture was continued 
for 24 h. Incorporation of [3H]thymidine into 
DNA was determined as in [4]. One unit of HGF 
activity is defined as that equivalent o half the 
amount of EGF required for maximum stimula- 
2.5. Flow-through on DE 52 column 
The material released from platelets of 300-400 
rats was applied to a DE 52 column (1.6 × 14 cm) 
previously equilibrated with 10 mM Hepes buffer 
(pH 7.2) containing 0.15 M NaC1 and 2mM 
CaC12. The flow-through fraction was collected 
and adjusted to pH 8.5 with 1 M Tris. 
2.6. Mono S FPLC 
The flow-through fraction from the DE 52 col- 
umn was applied to a Mono S column (1 x 10 cm) 
equilibrated with 50 mM Tris-HC1 buffer (pH 8.5) 
containing 0.15 M NaC1, 10mM Hepes, and 
2 mM CaC12. The column was washed with the 
same buffer and then HGF was eluted with a linear 
gradient of 0.15-1.0 M NaC1 in the same buffer at 
a flow rate of 60 ml/h. For assay of HGF activity, 
20-/A aliquots of all fractions were diluted with 
24 vols of a solution of bovine serum albumin 
(BSA, 2.5 mg/ml) in PBS and sterilized by filtra- 
tion through a 0.22/zm filter (Millex GV, 
Millipore). 
2.7. Affinity chromatography on a heparin- 
Sepharose CL-6B column 
Active fractions obtained from the Mono S 
FPLC step were pooled, adjusted to pH 7.5 with 
1 N HC1, and diluted with 3 vols distilled water. 
The diluted sample was applied to a heparin- 
Sepharose CL-6B column (1 x 5 cm) previously 
equilibrated with 10 mM Tris-HC1 buffer (pH 7.5) 
containing 0.3 M NaC1. The column was washed 
with 10 column volumes of the equilibration buf- 
fer, and then HGF was eluted with 30 ml of a gra- 
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dient of 0.3-2.0 M NaCI at a flow rate of 20 ml/h. 
For assay of HGF activity, 10/A aliquots of all 
fractions were diluted with 49 vols of a solution of 
2.5 mg/ml  BSA in PBS and sterilized by Millipore 
filtration as described above. 
2.8. Reverse-phase HPLC on a C4 column 
Active fractions obtained by heparin affinity 
chromatography were combined and applied to a 
Hi-pore Rp 304 column (4.6 x 250 mm) 
equilibrated with 0.1 °7o trifluoroacetic acid. HGF 
was eluted with a linear gradient of 0-90°7o 
acetonitrile in 0.1 °7o trifluoroacetic acid at a flow 
rate of 1 ml/min. Fractions of 1 ml were collected 
and promptly neutralized by adding 0.2 ml of 
0.1% sodium bicarbonate. HGF activity was 
assayed after 200-fold dilution of the samples with 
BSA and sterilization by Millipore filtration. 
2.9. SDS-polyacrylamide g l electrophoresis 
SDS-PAGE of purified HGF was performed in 
12.5% acrylamide gel as described by Laemmli 
[18]. After electrophoresis, the gel was fixed and 
stained with silver [19]. 
3. RESULTS 
3.1. Purification of HGF from rat platelets 
Previously we purified HGF from rat platelets 
via a three-step procedure [15]; namely, we 
stimulated its release from platelets by thrombin, 
and then purified it by cation-exchanger FPLC on 
a Mono S column and heparin-Sepharose CL-6B 
chromatography. However, this purified HGF was 
still contaminated with other proteins as judged by 
SDS-PAGE. Therefore, in this work we tried to 
purify HGF to homogeneity by reverse-phase 
HPLC.  For this the HGF preparation obtained 
from the platelets of 1000 adult rats by our 
previous three-step rocedure was applied to a Hi- 
pore Rp 304 column (4.6 x 250 mm, Bio-Rad Ca 
column) equilibrated with 0.1070 trifluoroacetic 
acid. Fig.1 shows the elution pattern of HGF. A 
large peak of contaminating protein with no activi- 
ty was eluted with 40°70 acetonitrile, and then on 
increasing the acetonitrile concentration to 43°70, 
HGF was eluted as a sharp peak. All fractions of 
eluate were neutralized with 1070 sodium bicar- 
bonate just after elution from the Hi-pore Rp 304 
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Fig. 1. Reverse-phase HPLC of HGF. A sample of 5 ml of the active fraction (5 ml) from a heparin-Sepharose column 
was injected into a Hi-pore Rp 304 column and eluted with a gradient 0-90°70 acetonitrile in 0.1 070 trifluoroacetic acid. 
Fractions of 1 ml were collected, promptly neutralized with 0.1 070 NaHCOa and their activity measured. ( - - - )  Relative 
A280; ( ) acetonitrile gradient; (bars) HGF activity. 
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column, since HGF is an acid-labile protein. When 
the fractions were promptly neutralized, we could 
obtain HGF in high yield even by reverse-phase 
HPLC under acidic conditions with 0.1 °70 
trifluoroacetic acid. Results of a typical purifica- 
tion are summarized in table 1. About 23/zg pure 
HGF was obtained from platelets of 1000 rats. The 
specific activity of the final preparation was 
calculated to be 46.1 × 104 U/mg protein. Thus, 
this preparation had much higher specific activity 
than that of our previous preparation (38.5 × 
l0 g U/mg protein). The overall recovery of HGF 
activity was 24°7o with 15897-fold increase in 
specific activity over that in the crude preparation 
released from platelets. 
Fig.2 shows the dose-response curve to the 
purified HGF obtained by reverse-phase HPLC. 
HGF had a detectable ffect at a concentration as 
low as 1 ng/ml and was maximally effective at 
5 ng/ml. The maximum activity was almost twice 
as potent as that of EGF. Its effect was additive or 
synergistic with those of insulin and EGF, as 
reported previously. Purified HGF did not 
stimulate DNA synthesis in Balb/c or Swiss 3T3 
cells. HGF activity was almost completely inac- 
tivated by heating (100°C, 3 min), or treatment 
with 1 N acetic acid or trypsin, as reported in [15]. 
3.2. Analysis of the subunit composition of HGF 
The HGF obtained by reverse-phase HPLC was 
subjected to SDS-PAGE. HGF migrated as a 
single band in a position corresponding to a 
molecular mass of 82 kDa, as shown in fig.3. The 
HGF activity, assayed as activity for stimulating 
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Fig.2. Dose-response curve for effect of pure HGF on 
DNA synthesis of adult rat hepatocytes in primary 
culture. Pure HGF, obtained by reverse-phase HPLC, 
was diluted with BSA (2.5 mg/ml) and sterilized. Then 
its HGF activity at the indicated concentrations was 
assayed. Protein was measured by amino acid analysis. 
Values are means for triplicate dishes. 
DNA synthesis of adult rat hepatocytes in primary 
culture, in eluates of gel slices was also detected in 
the position of the 82 kDa band on SDS-PAGE 
under non-reducing conditions (not shown). 
Table 1 
Purification of HGF from platelets of 1000 rats 
Purification step Protein Activity Spec. act. Purity Recovery 
(mg) (U × 10) (U/mg protein × 10) (-fold) (070) 
Supernatant from platelets 1541 44.3 0.029 1 100 
DE 52 run-through 1482 42.3 0.028 1 95 
Mono S FPLC 5.93 28.8 4.86 168 65 
Heparin-Sepharose 0.057 13.8 241 8310 31 
Reverse-phase HPLC 0.023 10.6 461 15 897 24 
Material released from platelets of 1000 rats was used as starting material. HGF activity was measured at four 
different concentrations and was determined from the linear portion of the dose-response curve. Protein 
concentration was calculated from the absorbance at280 nm up to the step of Mono S FPLC and by amino 
acid analysis in subsequent s eps 
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Fig.3. SDS-PAGE of purified HGF under reducing and 
non-reducing conditions. HGF samples (20/A, 0.1/zg) 
with or without reatment with 2-mercaptoethanol were 
subjected to SDS-PAGE as described in section 2. The 
molecular mass (in kDa) markers used were as follows: 
glycogen phosphorylase, 94; BSA, 67; ovalbumin, 43; 
carbonic anhydrase, 30; soybean trypsin inhibitor, 20.1; 
lactalbumin, 14.4. Lane 1, unreduced HGF; lane 2, 
reduced HGF. 
However, on SDS-PAGE under reducing condi- 
tions, purified HGF gave two bands with 
molecular masses of 69 and 34 kDa, respectively 
(fig.3). Neither fraction of reduced HGF had any 
biological activity. These findings indicate that 
HGF consists of two different polypeptide chains, 
linked covalently by a disulfide bond to form a 
molecule with a heterodimer. The value of 82 kDa 
calculated as the molecular mass of HGF from its 
mobility on SDS-PAGE under non-reducing con- 
ditions, may be apparent, because calculated 
values become less accurate with increase in 
molecular mass. Thus the value of 103 kDa obtain- 
ed as the sum of the molecular masses of two 
subunits may be more accurate. 
4. DISCUSSION 
Previously, we demonstrated that the serum of 
rats after partial hepatectomy contained a 
hepatotropic factor that stimulated DNA synthesis 
of mature hepatocytes in primary culture, and we 
named this factor hepatocyte growth factor (HGF) 
or hepatotropin [12]. We found that the HGF ac- 
tivity in rat serum increased time-dependently after 
partial hepatectomy, reaching a maximum of 
about 5-fold the initial level 24 h after the opera- 
tion. Moreover, we recently observed a marked in- 
crease in HGF activity in rat plasma after liver 
injury by administration of D-galactosamine or 
CCl4 to rats (in preparation). The serum-derived 
HGF was a heat- and acid-labile protein with a 
molecular mass of over 100-150 kDa, as judged 
by gel filtration on Sephadex G-200. Later, it 
became vident hat HGF is stored in rat platelets 
and released on their aggregation induced by 
thrombin treatment [12-14]. Recently, using 
purified HGF from rat platelets we found that the 
serum- and platelet-derived HGFs have almost he 
same properties. Moreover, Selden et al. [20] 
observed that HGF activity increased markedly in 
the serum of patients after partial hepatectomy for 
removal of hepatomas and Nakayama et al. [21] 
observed high HGF activity in sera of patients with 
fulminant hepatic failure. Furthermore, Gohda et 
al. [22] partially purified HGF from the plasma of 
patients with fulminant hepatic failure, and found 
that human HGF has very similar biological and 
chemical properties to rat HGF purified from 
platelets. These findings indicate that HGF is the 
hepatotropic factor that has long been suspected to 
exist. 
We have reported that HGF purified from rat 
platelets stimulated DNA synthesis of adult rat 
hepatocytes in primary culture but not of 
fibroblasts uch as Balb/c or Swiss 3T3 cells [12]. 
In contrast, various known growth factors, such as 
fibroblast growth factor, insulin-like growth fac- 
tors I and II, transferrin, and thrombin as well as 
PDGF, did not stimulate DNA synthesis in 
cultured rat hepatocytes, but stimulated the 
growth of 3T3 cells. Moreover, here we found that 
the molecular mass and subunit structure of HGF 
differ from those of various other growth factors. 
HGF has a high molecular mass and is a 
heterodimer composed of a large subunit of 
69 kDa and a small subunit of 34 kDa. To our 
knowledge, HGF is the largest growth factor that 
has been isolated so far. In addition to PDGF, 
platelets contain several mitogens uch as platelet 
basic protein [23], connective tissue activating pep- 
tide II I  [24], and ~-type transforming rowth fac- 
tor [25]. All these growth factors are heat- and 
acid-stable factors and are mitogenic to cells de- 
rived from mesenchymal tissues. Moreover, the ~- 
type transforming growth factor inhibits DNA 
synthesis in primary cultured hepatocytes 
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stimulated by insulin and EGF [26-28]. Thus, 
HGF also differs from various other platelet- 
derived growth factors besides PDGF in cell 
specificity and chemical properties including 
molecular size. Therefore, these findings indicate 
that HGF is a new growth factor for adult rat 
hepatocytes in rat platelets. Furthermore, it seems 
to be a main factor in the stimulation of liver 
regeneration after partial hepatectomy and liver 
injury. 
HGF may be useful clinically for enhancing liver 
regeneration after surgical operations on the liver 
and for treatment of patients with hepatitis. For 
this purpose, a method is required for large-scale 
preparation of human HGF. Molecular cloning of 
cDNA coding for human HGF and preparation of 
an expression vector are necessary for elucidating 
the chemical structure of HGF and for large-scale 
preparation of human HGF for clinical use. We 
are now cloning HGF cDNA from a cDNA library 
constructed from poly(A) RNA of rat 
megakaryocytes using a DNA probe corresponding 
to the N-terminal part of the amino acid sequence 
of rat HGF. 
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